tirzepatide maker zepbound manufacturer eli lilly to sell directly to consumers without insurance coverage Eli Lilly to sell Zepbound – Eli Lilly launches weight-loss drug

Others move through Bridge

Discover how Trizepatide can help you control your cravings and support your weight loss journey

A clinician who understands your broader chart may be better positioned to evaluate contraindications, medication interactions, and non-GLP-1 contributors to weight gain

Change from Baseline (%) in Body Weight (Study 4 on Left and Study 5 a on Right) with WEGOVY Injection Observed values for patients completing each scheduled visit, and estimates with multiple imputations from retrieved dropouts (RD-MI)

Clinical Evidence Supporting Tirzepatide for Hypertension Recent clinical trials on Tirzepatide have demonstrated notable reductions in systolic and diastolic blood pressure